
Lidocaine 2% Injection, MDV 50mL 25/Pack
Eyecare Professionals Only
Are you a licensed eyecare professional?
New registrations: Enter your email and we'll send a verification code. Check your spam folder.
Not an eyecare professional?
Visit Retail SiteLidocaine HCl 2% Injection, 25 x 50 mL Multiple-Dose Vials — Camber Pharmaceuticals
NDC: 31722-217-32
Product Details
| Active Ingredient | Lidocaine hydrochloride 20 mg/mL (2%); 1,000 mg per 50 mL vial |
| Dosage Form | Sterile injectable solution, multiple-dose vial |
| Route | Infiltration and perineural administration for local or regional anesthesia/analgesia |
| Package Size | 50 mL per vial; 25 vials per pack |
| Manufacturer | Camber Pharmaceuticals, Inc. |
| NDC | 31722-217-32 |
Indications and Usage
Lidocaine hydrochloride injection is indicated in adults and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and obstetrical procedures, in accordance with the approved product labeling.
Dosage and Administration
Dosage varies depending on the procedure, the area to be anesthetized, the depth and duration of anesthesia required, and the patient's individual response. Use the lowest effective dose necessary to produce the desired effect. This 2% formulation is labeled for infiltration and nerve block and is not for caudal or epidural use. Refer to the full prescribing information for specific dosing recommendations and maximum dosage limits.
Warnings and Precautions
- Systemic toxicity: Excessive systemic exposure may cause dose-related central nervous system and cardiovascular toxicity.
- Intravascular injection: Avoid inadvertent intravascular administration. Aspirate before and periodically during injection, as appropriate.
- Methemoglobinemia: Lidocaine may cause methemoglobinemia.
- Use in at-risk patients: Exercise caution in patients with hepatic impairment, cardiovascular disease, or other conditions that may increase the risk of systemic toxicity.
- Preservative: This product contains methylparaben.
- Administration restriction: This product is not for caudal or epidural use.
Contraindications
Contraindicated in patients with known hypersensitivity to lidocaine, other amide-type local anesthetics, or any component of the formulation.
Adverse Reactions
Adverse reactions associated with systemic lidocaine exposure may include central nervous system effects such as lightheadedness, dizziness, drowsiness, nervousness, tremor, tinnitus, confusion, and seizures. Cardiovascular effects may include hypotension, bradycardia, arrhythmias, and cardiovascular collapse. Allergic reactions and methemoglobinemia may also occur.
Storage and Handling
Store at 20°C to 25°C (68°F to 77°F) in accordance with USP Controlled Room Temperature requirements. Protect from light. Do not use if the solution is discolored or contains a precipitate.
How Supplied
Lidocaine HCl Injection, USP 2%, is supplied as a sterile, nonpyrogenic solution containing 1,000 mg/50 mL (20 mg/mL) in 50 mL multiple-dose vials, with 25 vials per carton.
NDC: 31722-217-32
Professional use only.
Clinical information is summarized from FDA-approved prescribing information (Structured Product Labeling). Refer to the full prescribing information via DailyMed for complete details.
If you have questions related to DSCSA compliance, transaction history, regulatory data, or quality assurance, please contact our team at compliance@dryeyerescue.com.
- NDC
- 31722-217-32
- Manufacturer
- Camber Pharmaceuticals
Ships in 1–2 business days
Standard transit is 3–5 business days within the contiguous US. Tracking is included with every shipment.
30-day returns on unopened items
Return unopened products in original packaging within 30 days for Vision Rescue Pro store credit. Return shipping is the customer's responsibility.
Some items can't be returned
Federal regulations prohibit returns on RX medications. Regener Eyes Pro and other prescription items are also non-returnable.




